FITC Anti-CD73 antibody [AD2]
Be the first to review this product! Submit a review
|
(12 Publications)
Mouse Monoclonal CD73 antibody - conjugated to FITC. Suitable for Flow Cyt and reacts with Human samples. Cited in 12 publications.
View Alternative Names
CD73, NT5, NTE, NT5E, 5'-nucleotidase, 5'-NT, 5'-deoxynucleotidase, Ecto-5'-nucleotidase, IMP-specific 5'-nucleotidase, Thymidylate 5'-phosphatase
- Flow Cyt
Supplier Data
Flow Cytometry - FITC Anti-CD73 antibody [AD2] (AB239246)
Flow cytometric analysis of human peripheral blood labeling CD73 with ab239246. Surface staining. Gated on leukocytes.
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD73 participates in the regulation of purinergic signaling through adenosine production. It acts in cooperation with other cell surface enzymes such as CD39 forming a functional complex that handles ATP breakdown to adenosine. This enzymatic activity modulates immune responses tissue protection and inflammation control. In addition to immune-related functions CD73 supports the maintenance of vascular integrity and proper cellular adhesion which is important in different physiological and pathological contexts.
Pathways
CD73 plays an important part in the adenosinergic pathway governing the conversion of AMP into adenosine. This activity impacts the signaling and function of the adenosine receptors on immune and non-immune cells. Another important pathway is the angiogenesis process where CD73 contributes by affecting endothelial cell migration and blood vessel development. Relationships with key proteins such as adenosine A2 receptors help facilitate these critical pathway activities.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Regenerative therapy 25:35-48 PubMed38058606
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2022:2164057 PubMed36311041
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:535 PubMed35672285
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 166:161-167 PubMed34747415
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 7:224 PubMed34455417
2021
Applications
Unspecified application
Species
Unspecified reactive species
Therapeutic advances in chronic disease 12:20406223211007369 PubMed33995992
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:1867-1883 PubMed33417281
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 7:577578 PubMed33425934
2020
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 11:455 PubMed33109266
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 11:441 PubMed32528301
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com